Maintenance
Staying on a dose, stepping down, or living after the steepest part of loss.
Peer stories for learning — talk with your clinician about what applies to you.

UK Mounjaro look-back — toward maintenance
By Aimee May
Published
“The years are going to pass anyway.”

From 225 to 133 on Zepbound at 67
By Lynn Becker
Published
“Most of the loss happened while I stayed on a modest dose.”

The dirty truths of my Mounjaro journey (Q&A)
By Aimee May
Published
“Needing a tool isn’t a character flaw.”